US-based pharmaceutical company Moderna on Wednesday said that they have requested the Food and Drug Administration for an emergency use authorisation of COVID-19 vaccine to be given to people in their teens.

Along with Pfizer, Moderna’s COVID-19 vaccine is already being used for all people above 18 years of age. Earlier, Moderna submitted a request application to the Canadian and European health regulators for approval of COVID-19 vaccination in teens.

Also ReadIndia's COVID vaccine basket set to get bigger. What's on offer

Pfizer on May 10 received approval to use the COVID-19 vaccine on kids below 18 years of age. 

Stephen Bancel, the CEO of Moderna said, “We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID and SAR COV-2 infections at adolescents."

Children with COVID-19 only develop mild symptoms or no symptoms but are at risk of becoming seriously ill. Moderna’s two-shot is around 90% effective against symptomatic COVID-19 and 95 % effective against severe disease. There were no specific symptoms apart from headache, fatigue, and body ache.

Also ReadCap on COVID vaccine prices in private hospitals. Read rate list

 Joe Biden, President of the United States, has already set a target that at least 70% of the adults should be vaccinated by July 4. As of June 10, 64% of the population has been partially vaccinated, as per the data.